Tag: thrombolysis
Surmodics receives US FDA 510(k) clearance for Pounce XL thrombectomy system
Surmodics has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for its Pounce XL thrombectomy system.
The Pounce XL thrombectomy...
First-in-human study of SonoThrombectomy system completed
SonoVascular has announced the successful initiation of its first-in-human study (FIH) of the company's SonoThrombectomy system, an ultrasound-facilitated, thrombolytic-enhanced platform that utilises multiple mechanisms...
Thrombolex announces new insights from the RESCUE trial with the Bashir...
Thrombolex has announced never-before-reported major reductions in obstruction in all of the segmental pulmonary arteries (PA), based on independent core lab data analysis of...
RESCUE trial shows reduction in segmental and main pulmonary artery occlusions
Robert A Lookstein, who is executive vice chair, Diagnostic, Molecular and Interventional Radiology at the Icahn School of Medicine at Mount Sinai Hospital (New...
Thrombectomy for DVT associated with reduced ICU cost when compared with...
A retrospective review, presented as a late-breaking clinical trial at The VEINS (Venous Endovascular Interventional Strategies) 2022 (30–31 October, Las Vegas, USA), indicates that...
At six months, adjunctive mechanical thrombectomy associated with higher patency and...
A recent systematic review and meta-analysis showed that, in patients with iliofemoral deep vein thrombosis (DVT), percutaneous mechanical thrombectomy was associated with a higher...
SUNSET sPE thrombolysis trial presents interim analysis of ultrasound-guided versus standard...
The Standard vs ultrasound-assisted catheter thrombolysis for submassive pulmonary embolism (SUNSET sPE) trial, is an ongoing randomised, head-to-head, single-blinded clinical trial comparing ultrasound-assisted thrombolysis...
Setting the record straight: Clarifying the misconceptions of the ATTRACT trial
A special session during the pre-conference Day of Innovation and Science at the American Venous Forum annual meeting (AVF; 20–23 February, Tucson, USA) presented...
High lysis completeness “guarantees high success rates” of iliac vein stent...
A recent study on iliac vein stenting following catheter-directed thrombolysis for deep vein thrombosis (DVT) has shown that technical and clinical success require high...
ATTRACT results are “a springboard” for future pharmacomechanical thrombolysis research
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...
Ultrasound-enhanced catheter-directed thrombolysis as the standard of care for acute DVT
Ash Verma, Clearwater, USA, writes how last year, he happened upon a routine case that struck him as both totally unremarkable and absolutely extraordinary....